DE1518915A1 - Verfahren zur Herstellung von Steroidverbindungen - Google Patents

Verfahren zur Herstellung von Steroidverbindungen

Info

Publication number
DE1518915A1
DE1518915A1 DE19651518915 DE1518915A DE1518915A1 DE 1518915 A1 DE1518915 A1 DE 1518915A1 DE 19651518915 DE19651518915 DE 19651518915 DE 1518915 A DE1518915 A DE 1518915A DE 1518915 A1 DE1518915 A1 DE 1518915A1
Authority
DE
Germany
Prior art keywords
hydroxy
diene
fluoro
dione
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19651518915
Other languages
German (de)
English (en)
Inventor
Joseph Elks
Bailey Esme Joan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of DE1518915A1 publication Critical patent/DE1518915A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Details Of Garments (AREA)
DE19651518915 1964-01-28 1965-01-28 Verfahren zur Herstellung von Steroidverbindungen Withdrawn DE1518915A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3622/64A GB1070751A (en) 1964-01-28 1964-01-28 17-esters of 17-hydroxy-21-desoxy-steroids

Publications (1)

Publication Number Publication Date
DE1518915A1 true DE1518915A1 (de) 1969-08-14

Family

ID=9761806

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19651518915 Withdrawn DE1518915A1 (de) 1964-01-28 1965-01-28 Verfahren zur Herstellung von Steroidverbindungen

Country Status (15)

Country Link
US (1) US3376193A (enExample)
BE (1) BE658976A (enExample)
BR (1) BR6566679D0 (enExample)
CH (1) CH519489A (enExample)
CY (1) CY554A (enExample)
DE (1) DE1518915A1 (enExample)
DK (1) DK115547B (enExample)
ES (1) ES308634A1 (enExample)
FR (2) FR5292M (enExample)
GB (1) GB1070751A (enExample)
IL (1) IL22809A (enExample)
MY (1) MY7000161A (enExample)
NL (1) NL144947B (enExample)
NO (1) NO124689B (enExample)
SE (1) SE318564B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2512915A1 (de) * 1974-03-27 1975-10-09 Plurichemie Anstalt 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1034011B (it) * 1969-06-26 1979-09-10 Vister Vismara Terapeutici S P Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato
US3789121A (en) * 1971-11-26 1974-01-29 Warner Lambert Co 17{60 ,21-orthobutyrates of 6{60 , 9{60 -difluoro-hydrocortisone and 6{60 , 9{60 -difluoroprednisolone, compositions containing same and the use thereof as anti-inflammatory agents
GB1510617A (en) * 1974-03-27 1978-05-10 Plurichemie Anstalt 16-methyl-9alpha-halo steroid esters and ethers and preparation thereof
DE10302096B4 (de) * 2003-01-16 2005-03-17 Coty B.V. Kosmetische selbsterwärmende Produkte und deren Verwendung
US10920332B2 (en) 2015-01-19 2021-02-16 Council Of Scientific And Industrial Research Process for the preparation of corrosion resistance sealed anodized coatings on aluminum alloy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3115491A (en) * 1959-12-24 1963-12-24 Roussel Uclaf Process for the preparation of 11-substituted 17alpha, 21-dihydroxy-16alpha-methyl-9alpha-fluoro-delta1, 4-pregnadiene-3, 20-diones
DE1158507B (de) * 1960-10-29 1963-12-05 Merck Ag E Verfahren zur Herstellung von 6a-Methyl-16-methylen-steroiden
DE1195748B (de) * 1961-06-24 1965-07-01 Vismara Francesco Spa Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
US3104246A (en) * 1961-08-18 1963-09-17 Roussel Uclaf Process of preparation of beta-methasone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2512915A1 (de) * 1974-03-27 1975-10-09 Plurichemie Anstalt 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE1793630B2 (de) 1975-10-23
FR1472027A (fr) 1967-03-10
US3376193A (en) 1968-04-02
DK115547B (da) 1969-10-20
CY554A (en) 1970-08-18
NL144947B (nl) 1975-02-17
ES308634A1 (es) 1965-06-16
FR5292M (enExample) 1967-08-16
BE658976A (enExample) 1965-07-28
DE1793630A1 (de) 1971-07-08
NO124689B (enExample) 1972-05-23
MY7000161A (en) 1970-12-31
NL6501123A (enExample) 1965-07-29
BR6566679D0 (pt) 1973-08-02
SE318564B (enExample) 1969-12-15
GB1070751A (en) 1967-06-01
CH519489A (de) 1972-02-29
IL22809A (en) 1969-03-27

Similar Documents

Publication Publication Date Title
DE1518915A1 (de) Verfahren zur Herstellung von Steroidverbindungen
DE1518915C (de) 17 alpha Alkanoyloxy 9 alpha fluor 11 oxy bzw 11 beta hydroxy 16 beta methyl pregna 1,4 dien 3,20 dione und Verfahren zu deren Herstellung
DE2409971C3 (de) 5-Cholestenderivate und Verfahren zu ihrer Herstellung
DE957661C (de) Verfahren zur Herstellung von 17-Oxy-20-keto-21acyl-oxypregnanen
DE934768C (de) Verfahren zur Herstellung von Pregnanen
DE962791C (de) Verfahren zur Herstellung von 21-Bromallopregnanderivaten
DE825686C (de) Verfahren zur UEberfuehrung von í¸-20-Cyanpregnenen mit einer oder mehreren kerngebundenen Hydroxylgruppen in 17 alpha-Oxy-20-ketopregnane
DE957481C (de) Verfahren zur Herstellung von Steroidpseudosapogeninen aus Steroidsapogeninen oder deren Estern
DE960200C (de) Verfahren zur Herstellung von 4-Pregnen-16 ª‡-ol-3, 20-dionen
DE1518915B (de) 17 alpha-Alkanoyloxy-9 alpha-fluor-H-oxy-bzw. -11 beta-hydroxy-16 betamethyl-pregna-l,4-dien-3,20-dioneund Verfahren zu deren Herstellung
DE1264441B (de) Verfahren zur Herstellung von 17alpha-AEthinyl-delta 5(10-19-nor-androsten-17beta-ol-3-on und 17alpha-AEthynil-19-nor-testosteron sowie dessen Estern
DE843411C (de) Verfahren zur Gewinnung in 21-Stellung substituierter Pregnanderivate
AT241706B (de) Verfahren zur Herstellung von 18, 20-Laktonen der Pregnanreihe
DE929190C (de) Verfahren zur Herstellung von ª‡,ª‰-ungesaettigten Ketosteroiden
DE1000814B (de) Verfahren zur Herstellung von 17ª‡-Acyloxy-20-ketosteroiden der Pregnan-, Allopregnan- und Pregnenreihe
DE1170948B (de) Verfahren zur Herstellung von 6ª‡, 16ª‡-Dimethyl-11ª‰, 17ª‡, 21-trihydroxy-4-pregnen-3, 20-dion-bzw. dessen 21-Acetat
DEG0016144MA (enExample)
CH364776A (de) Verfahren zur Herstellung von 16-20-Keto-steroiden
DE1048914B (de) Verfahren zur Herstellung von Steroidverbindungen
DEU0003317MA (enExample)
CH339924A (de) Verfahren zur Herstellung von 17-Oxy-20-keto-21-acyloxysteroiden der Pregnan- oder Allopregnanreihe
DE1162839B (de) Verfahren zur Herstellung von 18-oxygenierten 21-Hydroxy-pregnanverbindungen
DE1081888B (de) Verfahren zur Herstellung von ?-3-Keto-9 ª‡-halogensteroiden
DE1174777B (de) Verfahren zur Herstellung von 2-Cyansteroid-3-ketonen oder deren Salzen
DE1203258B (de) Verfahren zur Herstellung von 3-Oxo-A4-6-methyl-steroiden

Legal Events

Date Code Title Description
E77 Valid patent as to the heymanns-index 1977
EHJ Ceased/non-payment of the annual fee